Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Eye, Ear, Nose and Throat›Corneal Opacity

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Corneal Opacity

Eye, Ear, Nose and Throat · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

Disorder occurring in the central or peripheral area of the cornea.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (840 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Corneal Opacities; Opacities, Corneal; Opacity, Corneal; Leukoma; Leukomas.

Where it fits in the MeSH classification

Broader topics
Corneal Diseases
Narrower topics
Arcus Senilis

Research landscape

PubMed indexes 4,429 records tagged with the MeSH heading “Corneal Opacity” (counts retrieved 2026-11-04). 404 of them (9.1%) were published from 2020 onward, and the busiest period so far is through 1999 with 2,541 records.

Reviews account for 267 records (6.0%) and meta-analyses for 5. Randomized controlled trials number 47 (1.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 2,541 records; 2000-2009: 678 records; 2010-2019: 806 records; 2020 onward: 404 records2,541through 19996782000-20098062010-20194042020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19992,541
2000-2009678
2010-2019806
2020 onward404
Share of records by publication typeReviews: 6.0 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 1.1 percentReviews6.0% (267)Meta-analyses0.1% (5)Randomized controlled trials1.1% (47)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 4,429 PubMed records
TypeRecordsShare
Reviews2676.0%
Meta-analyses50.1%
Randomized controlled trials471.1%

Method: PubMed query "Corneal Opacity"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in eye, ear, nose and throat

Eye, hearing, nose and throat studies rely on specialist tests (visual acuity, eye pressure, audiograms, scopes) and on patient-reported symptoms, which vary between people and with age. Some conditions improve without treatment, so comparison groups matter. Nothing on this page is advice about diagnosis or treatment; sudden loss of sight or hearing needs urgent care from a qualified clinician. Check how the outcome was tested, the age of the people studied and how long they were followed.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Ketamine/Xylazine-Induced Corneal Damage in Mice
Koehn D, Meyer KJ, Syed NA, Anderson MG
2015Research article
Design not recorded in structured metadata
42cc0
PMID 26222692 · DOI · PMC4519051
FOXE3 contributes to Peters anomaly through transcriptional regulation of an autophagy-associated protein termed DNAJB1
Khan SY, Vasanth S, Kabir F, Gottsch JD, Khan AO, Chaerkady R, et al.
2016Research article
Design not recorded in structured metadata
38cc by
PMID 27218149 · DOI · PMC4820811
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
Lee SH, Kim KW, Joo K, Kim JC
2016Research article
Design not recorded in structured metadata
26cc by
PMID 27356868 · DOI · PMC4926301
Artificial intelligence derived grading of mustard gas induced corneal injury and opacity
Kumar R, Sinha DM, Sinha NR, Tripathi R, Hesemann N, Gupta S, et al.
2025Research article
Design not recorded in structured metadata
1cc by
PMID 40594758 · DOI · PMC12216909

Ketamine/Xylazine-Induced Corneal Damage in Mice [1]

Research article Koehn D, Meyer KJ, Syed NA, Anderson MG · · 2015 · cited 42 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
PurposeWe have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity.
Closing excerpt
Use of yohimbine is suggested as a practical means of avoiding this complication.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (227 words)

PurposeWe have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity. The purpose of this study was to establish the clinical and histological features of this deleterious side effect, its sensitivity with respect to age and anesthesia protocol, and approaches for avoiding it.MethodsYoung C57BL/6J, C57BLKS/J, and SJL/J mice were treated with permutations of anesthesia protocols and compared using slit-lamp exams, optical coherence tomography, histologic analyses, and telemetric measurements of body temperature.ResultsKetamine/xylazine induces corneal damage in mice with a variable frequency. Among 12 experimental cohorts, corneal damage associated with ketamine/xylazine was observed in 9 of them. Despite various treatments to avoid corneal dehydration during anesthesia, the frequency of corneas experiencing damage among responding cohorts was 42% (26% inclusive of all cohorts), which is significantly greater than the natural prevalence (5%). The damage was consistent with band keratopathy. It appeared as a white or gray horizontal band located proximal to the pupil and was positive for subepithelial calcium deposition with von Kossa stain.ConclusionsThe sum of our clinical and histological observations is consistent with ketamine/xylazine-induced band keratopathy in mice. This finding is relevant for mouse studies involving the eye and/or vision-dependent behavioral assays, which would both be prone to artifact without appreciation of the damage caused by ketamine/xylazine anesthesia. Use of yohimbine is suggested as a practical means of avoiding this complication.

Abstract reproduced from the open-access article under the recorded cc0 licence; © the authors. PMID 26222692 · DOI · PMC4519051

FOXE3 contributes to Peters anomaly through transcriptional regulation of an autophagy-associated protein termed DNAJB1 [2]

Research article Khan SY, Vasanth S, Kabir F, Gottsch JD, Khan AO, Chaerkady R, et al. · · 2016 · cited 38 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
FOXE3 is a lens-specific transcription factor that has been associated with anterior segment ocular dysgenesis.
Closing excerpt
In conclusion, here we report DNAJB1 is a transcriptional target of FOXE3 in a novel pathway that is crucial for the development of the anterior segment of the eye.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (147 words)

FOXE3 is a lens-specific transcription factor that has been associated with anterior segment ocular dysgenesis. To determine the transcriptional target(s) of FOXE3 that are indispensable for the anterior segment development, we examined the transcriptome and the proteome of cells expressing truncated FOXE3 responsible for Peters anomaly identified through linkage-coupled next-generation whole-exome sequencing. We found that DNAJB1, an autophagy-associated protein, was the only candidate exhibiting differential expression in both screens. We confirmed the candidacy of DNAJB1 through chromatin immunoprecipitation and luciferase assays while knockdown of DNAJB1 in human lens epithelial cells resulted in a mitotic arrest. Subsequently, we targeted dnajb1a in zebrafish through injection of a splice-blocking morpholino. The dnajb1a morphants exhibited underdeveloped cataractous lenses with persistent apoptotic nuclei. In conclusion, here we report DNAJB1 is a transcriptional target of FOXE3 in a novel pathway that is crucial for the development of the anterior segment of the eye.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27218149 · DOI · PMC4820811

Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts [3]

Research article Lee SH, Kim KW, Joo K, Kim JC · · 2016 · cited 26 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundAngiogenin (ANG), a component of tears, is involved in the innate immune system and is related with inflammatory disease.
Closing excerpt
This may support the targeting of immune-mediated corneal inflammation by using ANG.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (273 words)

BackgroundAngiogenin (ANG), a component of tears, is involved in the innate immune system and is related with inflammatory disease. We investigated whether ANG has an immune modulatory function in human corneal fibroblasts (HCFs).MethodsHCFs were cultured from excised corneal tissues. The gene or protein expression levels of interleukin (IL)-1beta (β), IL-4, IL-6, IL-8, IL-10, complements, toll-like receptor (TLR)4, myeloid differentiation primary response gene (MYD)88, TANK-binding kinase (TBK)1, IkappaB kinase-epsilon (IKK-ε) and nuclear factor-kappaB (NF-κB) were analyzed with or without ANG treatment in tumor necrosis factor-alpha (TNF-α)- or lipopolysaccharide (LPS)-induced inflammatory HCFs by real-time polymerase chain reaction (PCR), Western blotting and immunocytochemistry. Inflammatory cytokine profiles with or without ANG were evaluated through immunodot blot analysis in inflammatory HCFs. Corneal neovascularization and opacity in a rat model of corneal alkali burn were evaluated after application of ANG eye drops.ResultsANG decreased the mRNA levels of IL-1β, IL-6, IL-8, TNF-α receptor (TNFR)1, 2, TLR4, MYD88, and complement components except for C1r and C1s and elevated the mRNA expression of IL-4 and IL-10. Increased signal intensity of IL-6, IL-8 and monocyte chemotactic protein (MCP)-1 and MCP-2 induced by TNF-α or LPS was weakened by ANG treatment. ANG reduced the protein levels of IKK-ε by either TNF-α and LPS, and decreased TBK1 production induced by TNF-α, but not induced by LPS. The expression of NF-κB in the nuclei was decreased after ANG treatment. ANG application lowered corneal neovascularization and opacity in rats compared to controls.ConclusionThese results demonstrate that ANG reduces the inflammatory response induced by TNF-α or LPS in HCFs through common suppression of IKK-ε-mediated activation of NF-κB. This may support the targeting of immune-mediated corneal inflammation by using ANG.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27356868 · DOI · PMC4926301

Artificial intelligence derived grading of mustard gas induced corneal injury and opacity [4]

Research article Kumar R, Sinha DM, Sinha NR, Tripathi R, Hesemann N, Gupta S, et al. · · 2025 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Artificial intelligence (AI) has emerged as a transformative tool in ophthalmology for disease diagnosis and prognosis.
Closing excerpt
This deep learning framework, combining Mask-RCNN with ResNet50 allows reliable and uniform grading of SM-induced corneal injury and opacity levels in affected eyes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (193 words)

Artificial intelligence (AI) has emerged as a transformative tool in ophthalmology for disease diagnosis and prognosis. However, use of AI for assessing corneal damage due to chemical injury in live rabbits remains lacking. This study aimed to develop an AI-derived clinical classification model for an objective grading of corneal injury and opacity levels in live rabbits following ocular exposure of sulfur mustard (SM). An automated method to grade corneal injury minimizes diagnostic errors and enhances translational application of preclinical research in better human eyecare. SM induced corneal injury and opacity from 401 in-house rabbit corneal images captured with a clinical stereomicroscope were used. Three independent subject matter specialists classified corneal images into four health grades: healthy, mild, moderate, and severe. Mask-RCNN was employed for precise corneal segmentation and extraction, followed by classification using baseline convolutional neural network and transfer learning algorithms, including VGG16, ResNet101, DenseNet121, InceptionV3, and ResNet50. The ResNet50-based model demonstrated the best performance, achieving 87% training accuracy, and 85% and 83% prediction accuracies on two independent test sets. This deep learning framework, combining Mask-RCNN with ResNet50 allows reliable and uniform grading of SM-induced corneal injury and opacity levels in affected eyes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40594758 · DOI · PMC12216909

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article The corneal fibrosis response to epithelial-stromal injury [5]
    Torricelli AA, Santhanam A, Wu J, Singh V, Wilson SE · Exp Eye Res · 2016 · cited 233 times (Europe PMC)
  • Research article Corneal stromal wound healing: Major regulators and therapeutic targets [6]
    Kamil S, Mohan RR · Ocul Surf · 2021 · cited 150 times (Europe PMC)
  • Research article Transparency, swelling and scarring in the corneal stroma [7]
    Meek KM, Leonard DW, Connon CJ, Dennis S, Khan S · Eye (Lond) · 2003 · cited 149 times (Europe PMC)
  • Research article Pediatric keratoplasty [8]
    Vanathi M, Panda A, Vengayil S, Chaudhuri Z, Dada T · Surv Ophthalmol · 2009 · cited 123 times (Europe PMC)
  • Research article Trachoma [9]
    Wright HR, Turner A, Taylor HR · Lancet · 2008 · cited 123 times (Europe PMC)
  • Research article Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis [10]
    Wang EY, Kong X, Wolle M, Gasquet N, Ssekasanvu J, Mariotti SP, et al. · Ophthalmology · 2023 · cited 118 times (Europe PMC)

References

  1. Koehn D, Meyer KJ, Syed NA, Anderson MG. Ketamine/Xylazine-Induced Corneal Damage in Mice. . 2015. PMID 26222692 · DOI · PMC4519051
  2. Khan SY, Vasanth S, Kabir F, Gottsch JD, Khan AO, Chaerkady R, et al.. FOXE3 contributes to Peters anomaly through transcriptional regulation of an autophagy-associated protein termed DNAJB1. . 2016. PMID 27218149 · DOI · PMC4820811
  3. Lee SH, Kim KW, Joo K, Kim JC. Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts. . 2016. PMID 27356868 · DOI · PMC4926301
  4. Kumar R, Sinha DM, Sinha NR, Tripathi R, Hesemann N, Gupta S, et al.. Artificial intelligence derived grading of mustard gas induced corneal injury and opacity. . 2025. PMID 40594758 · DOI · PMC12216909
  5. Torricelli AA, Santhanam A, Wu J, Singh V, Wilson SE. The corneal fibrosis response to epithelial-stromal injury. Exp Eye Res. 2016. PMID 26675407 · DOI · PMC4683352
  6. Kamil S, Mohan RR. Corneal stromal wound healing: Major regulators and therapeutic targets. Ocul Surf. 2021. PMID 33127599 · DOI · PMC9183221
  7. Meek KM, Leonard DW, Connon CJ, Dennis S, Khan S. Transparency, swelling and scarring in the corneal stroma. Eye (Lond). 2003. PMID 14631399 · DOI
  8. Vanathi M, Panda A, Vengayil S, Chaudhuri Z, Dada T. Pediatric keratoplasty. Surv Ophthalmol. 2009. PMID 19298903 · DOI
  9. Wright HR, Turner A, Taylor HR. Trachoma. Lancet. 2008. PMID 18539226 · DOI
  10. Wang EY, Kong X, Wolle M, Gasquet N, Ssekasanvu J, Mariotti SP, et al.. Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis. Ophthalmology. 2023. PMID 36963570 · DOI · PMC10355344

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • CataractEye, Ear, Nose and Throat
  • Corneal EdemaEye, Ear, Nose and Throat
  • KeratoconusEye, Ear, Nose and Throat
  • Corneal NeovascularizationEye, Ear, Nose and Throat
  • Corneal StromaAnatomy and Physiology
  • AstigmatismEye, Ear, Nose and Throat

All 51 articles in Eye, Ear, Nose and Throat →

At a glance

4,429
PubMed records on this heading
9%
published since 2020
267
review articles
47
randomized trials
10
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • CataractEye, Ear, Nose and Throat
  • Corneal EdemaEye, Ear, Nose and Throat
  • KeratoconusEye, Ear, Nose and Throat
  • Corneal NeovascularizationEye, Ear, Nose and Throat
  • Corneal StromaAnatomy and Physiology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support